There has been a sharp increase in colorectal and pancreatic cancer rates among Americans under 55 years, despite declines in older adults, according to a new study.

U.S. medical centers are seeking FDA authorization for the compassionate use — or expanded access — of Namodenoson for ...

Scientists have identified a key vulnerability in pancreatic cancer by targeting transcription-replication conflicts—cellular ...

Dr. Nataliya Uboha sat down to discuss the early warning signs of esophageal cancer, as well as important key takeaways for ...

Many remember Bobby Jenks as the fearless closer who helped the Chicago White Sox capture a title. Now, the town’s hero is ...

Most of us would probably think of smoking or air pollution when it comes to lung cancer risk, but researchers have ...

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...

New research in JNCCN from The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center found ...

The following is a summary of "Quality of life and toxicity in patients with pancreatic ductal adenocarcinoma treated with ...